Investors who acquired Insulet Corporation securities between February 2025 and May 2026 are now represented in a federal class action lawsuit. Filed in the District of Massachusetts, the complaint accuses the insulin delivery manufacturer of obscuring defective production controls that allegedly compromised patient safety and misled the market.
Investors who suffered losses in Futu Holdings Ltd. shares have until August 25, 2026, to petition for lead plaintiff status in a newly filed class action lawsuit. The litigation centers on allegations of securities fraud linked to the company’s failure to secure necessary licenses for its cross-border operations.
A federal class action lawsuit has been filed against Microsoft, alleging the tech giant misled shareholders regarding the financial health and market adoption of its artificial intelligence initiatives. Investors claiming losses from the company's recent stock decline now have until August 11, 2026, to seek lead plaintiff status.
Pomerantz LLP has initiated a class action lawsuit against Datavault AI Inc. and its senior leadership, representing investors who purchased company securities between September 4, 2024, and October 30, 2025. The litigation follows allegations that the firm misled shareholders regarding its business operations and key corporate partnerships.
A federal class action lawsuit has been filed in the Middle District of Florida, accusing Pentwater Capital Management and its CEO Matthew Halbower of orchestrating a market manipulation scheme that triggered a massive, volatile short squeeze in Avis Budget Group shares between February 2025 and April 2026.
Shareholders who acquired Via Transportation stock following the company’s September 2025 initial public offering have until August 10, 2026, to seek lead plaintiff status. The class action lawsuit claims the firm misled investors regarding its growth trajectory and revenue stability during its high-profile market debut.
Investors who incurred losses following allegations of fraudulent business practices at ADMA Biologics, Inc. have until August 10, 2026, to petition the court for lead plaintiff status. The class action lawsuit follows a volatile spring period that saw the company’s stock price tumble after reports of potential revenue inflation.
Investors have launched a class action lawsuit against First Solar, Inc., alleging the company misled shareholders regarding its ability to navigate volatile U.S. tariff policies. The litigation follows a sharp decline in share price triggered by missed earnings and disclosures about production struggles at international manufacturing facilities.
A class action lawsuit filed in the U.S. District Court for the Northern District of Illinois accuses Wix.com of misleading shareholders regarding the competitiveness and financial burden of its artificial intelligence initiatives. The complaint centers on claims that the company inflated the performance of its AI tools while masking rising costs.
Investors who purchased Erasca, Inc. securities are being urged to join a class action lawsuit as the firm faces allegations of securities fraud. The legal action follows a tumultuous April 2026, during which the company dealt with patent infringement claims and the disclosure of a patient death in a clinical trial.
Investors have launched a class action lawsuit against BitGo Holdings, Inc., alleging the digital asset infrastructure firm misled shareholders regarding its financial health and risk exposure during its January 2026 initial public offering and the subsequent months of trading.
A class action lawsuit filed in the U.S. District Court for the Northern District of California alleges that Intuit Inc. misled investors regarding the company's competitive strength and growth projections, specifically concerning its TurboTax segment, between August 22, 2025, and May 20, 2026.
Investors who suffered losses tied to Embecta Corp. have until August 17, 2026, to petition the court for lead plaintiff status in a pending class action lawsuit. The litigation centers on allegations of securities fraud following a sharp collapse in the company’s market value earlier this year.
Investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025, and April 17, 2026, have initiated a class action lawsuit in the United States District Court for the District of New Jersey, alleging that the company and its top officials misled shareholders regarding production efficiency and operational costs.
Investors who held Zillow securities during the designated class period face an August 10, 2026, deadline to petition the court for lead plaintiff status. Pomerantz LLP has initiated a class action lawsuit against the real estate giant, alleging the company and its executives engaged in securities fraud and unlawful business practices.
Investors who purchased Park Ha Biological Technology Co., Ltd. securities between December 27, 2024, and July 8, 2025, are being urged to join a pending class action lawsuit. The case, filed by the Rosen Law Firm, alleges that the company misled shareholders regarding its true business operations and market activity.
Latin American shopping mall operator ALLOS S.A. reached R$340.8 million in Funds From Operations during the second quarter of 2026, marking a 12% year-over-year increase. Despite elevated interest rates, the company leveraged gains in its media and real estate development segments to bolster quarterly performance.
A class action lawsuit has been filed against PROCEPT BioRobotics Corporation, alleging the medical device manufacturer misled investors about the sustainability of its sales growth. The litigation focuses on claims that the company used aggressive discounting to artificially inflate revenue figures between February 2024 and February 2026.
A strategic collaboration between Energenesis Biomedical and Taiwan Tanabe Seiyaku aims to accelerate the development of ENERGI-F703DFU, a topical gel currently in Phase III clinical trials. The agreement focuses on process technology transfer and regulatory preparation for a potential new drug application in Taiwan.
California veterinary management group Pathway Vet Alliance LLC is facing a class action lawsuit filed in Orange Superior Court, with plaintiffs alleging a systemic failure to provide mandated meal and rest periods, alongside claims of unpaid wages and inaccurate itemized statements for its employees.
Investors who purchased Wix.com Ltd. securities between February 19, 2025, and May 12, 2026, are being urged to join a newly filed class action lawsuit. The legal action, spearheaded by Rosen Law Firm, alleges that the company misled shareholders regarding the financial and competitive standing of its AI-driven product portfolio.
Investors who purchased Primoris Services Corporation common stock between August 5, 2025, and June 22, 2026, face a September 21, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit filed by the Rosen Law Firm regarding alleged misleading financial disclosures.
Shareholders of Pentair plc have until October 2, 2026, to apply for lead plaintiff status in a pending class action lawsuit. The litigation centers on allegations that the company concealed significant inventory destocking issues within its critical Pool segment while simultaneously issuing optimistic financial guidance earlier this year.
A securities class action lawsuit has been filed against ARS Pharmaceuticals following a 23.9% single-day stock collapse on June 25, 2026. The litigation alleges the company misled investors by failing to disclose the significant risk that a critical CVS Caremark formulary expansion would slip from July 2026 to January 2027.
A 22% plunge in Disc Medicine’s stock price following an FDA rejection has triggered a formal investigation by the Rosen Law Firm. The firm is now evaluating potential securities claims, alleging that the biotech company provided investors with materially misleading information regarding its bitopertin drug program.
A 25.3% single-day collapse in UP Fintech Holding Limited shares has triggered a formal investigation by the Rosen Law Firm. The legal action centers on claims that the NASDAQ-listed broker provided investors with materially misleading business information regarding its regulatory standing in China.
Fifty-two percent of organizations now deploy agentic AI within their security operations, yet only 25 percent formally assess these investments. A 2026 Omdia market update suggests this oversight deficit creates a dangerous disconnect, where the speed of autonomous adoption vastly outpaces the governance frameworks required to control high-impact machine decisions.
Exploration drilling at Perpetua Resources’ Stibnite project in Idaho has unearthed high-grade gold, antimony, and tungsten deposits, prompting the company to seek federal funding for a expanded critical minerals program. The findings, derived from the first exploratory drilling in nearly a decade, signal a strategic pivot toward domestic tungsten production.
Solidion Technology has effectively neutralized its going concern risk, reporting a significant balance sheet turnaround following a $35 million private placement. The Dallas-based battery developer, which ended 2025 with just $0.2 million in cash, bolstered its liquidity to $27.7 million by the close of the second quarter.
Ten veteran professionals who redefined the Southern California landscape through architecture, legal advocacy, and land development are set to join the Building Industry Association of Southern California’s Hall of Legends. These honorees will be formally recognized this fall for their decades of influence on regional housing and community growth.
